Bowel Preparation
Conditions
Interventions
3L PEG + LB group:Use of rupiprostenone before bowel preparation
2L PEG + LB group:Use of rupiprostenone before bowel preparation
4L PEG group:control group 1
3L PEG group:control group 12
Sponsors
The Affiliated People’s Hospital of Ningbo University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) 18 to 75 years of age, male or female; (2) proposed to undergo diagnostic, screening, or surveillance colonoscopy; (3) signed written informed consent;
Exclusion criteria
Exclusion criteria: Severe cardiac, cerebral, pulmonary, or renal comorbidities or a history of acute myocardial infarction or stroke within 6 months; history of abdominal or pelvic surgery; pregnant and breastfeeding women; high-risk factors for intestinal preparations, such as inflammatory bowel disease, or intestinal obstruction; fecal Bristol score of 7 (watery, no solid mass); and participation in other interventional clinical trials within 3 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bowel preparation quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| insertion time and withdrawal time;detection rate of adenoma and adenocarcinoma;incidence rate of adverse reaction in bowel preparation;willingness to undergo repeat bowel preparation; | — |
Countries
China
Contacts
Public ContactHongliang Li
The Affiliated People’s Hospital of Ningbo University
Outcome results
None listed